Advertisement

Index by Author

January 1992; 41 (1)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Akots, G

    • Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88

  2. Almdal, T P

    • Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. Diabetes January 1992 41:12-16; doi:10.2337/diabetes.41.1.12

  3. Asano, T

    • Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes January 1992 41:22-25; doi:10.2337/diabetes.41.1.22

B

  1. Baba, M

    • Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47

  2. Barbosa, J J

    • Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53

  3. Baxter, M A

    • Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35

  4. Bernard, N F

    • High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes January 1992 41:40-46; doi:10.2337/diabetes.41.1.40

  5. Bhushan, R

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  6. Borboni, P

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  7. Bowden, D W

    • Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88

  8. Brown, G

    • Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35

  9. Brownlee, M

    • Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes January 1992 41:26-29; doi:10.2337/diabetes.41.1.26

  10. Bunce, C M

    • Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35

C

  1. Caprio, S

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  2. Chonko, A M

    • Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62

  3. Cingolani, H E

    • Effect of diabetes on fast response to norepinephrine in rat aorta. Diabetes January 1992 41:30-34; doi:10.2337/diabetes.41.1.30

  4. Condorelli, L

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

D

  1. De Pirro, R

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  2. Diaz, J L

    • T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM. Diabetes January 1992 41:118-121; doi:10.2337/diabetes.41.1.118

E

  1. Edelstein, D

    • Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes January 1992 41:26-29; doi:10.2337/diabetes.41.1.26

  2. Ertug, F

    • High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes January 1992 41:40-46; doi:10.2337/diabetes.41.1.40

F

  1. Fajans, S S

    • Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88

  2. Finegold, D N

    • Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107

  3. Frankel, W N

    • NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes January 1992 41:98-106; doi:10.2337/diabetes.41.1.98

  4. Fukumoto, H

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

G

  1. Goldfine, I D

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  2. Grafton, G

    • Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35

  3. Gravius, T C

    • Identification of genetic markers flanking the locus for maturity-onset diabetes of the young on human chromosome 20. Diabetes January 1992 41:88-92; doi:10.2337/diabetes.41.1.88

H

  1. Hammonds, P

    • T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM. Diabetes January 1992 41:118-121; doi:10.2337/diabetes.41.1.118

  2. Haring, H U

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  3. Ha, T L

    • Dysfunction of insulin mediator protein kinase FA in lymphocytes of patients with NIDDM. Diabetes January 1992 41:68-75; doi:10.2337/diabetes.41.1.68

  4. Heindorff, H

    • Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. Diabetes January 1992 41:12-16; doi:10.2337/diabetes.41.1.12

  5. Herron, K G

    • Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62

  6. Holst, J J

    • Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. Diabetes January 1992 41:12-16; doi:10.2337/diabetes.41.1.12

  7. Hwang, H S

    • Dysfunction of insulin mediator protein kinase FA in lymphocytes of patients with NIDDM. Diabetes January 1992 41:68-75; doi:10.2337/diabetes.41.1.68

I

  1. Imura, H

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  2. Inagaki, N

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  3. Ishihara, H

    • Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes January 1992 41:22-25; doi:10.2337/diabetes.41.1.22

J

  1. Jean, Y J

    • Dysfunction of insulin mediator protein kinase FA in lymphocytes of patients with NIDDM. Diabetes January 1992 41:68-75; doi:10.2337/diabetes.41.1.68

K

  1. Kamijo, M

    • Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47

  2. Karlsen, A E

    • Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82

  3. Katagiri, H

    • Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes January 1992 41:22-25; doi:10.2337/diabetes.41.1.22

  4. Kowalyk, S

    • Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82

L

  1. Lai, Y G

    • Dysfunction of insulin mediator protein kinase FA in lymphocytes of patients with NIDDM. Diabetes January 1992 41:68-75; doi:10.2337/diabetes.41.1.68

  2. Lauro, R

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  3. Leiter, E H

    • NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes January 1992 41:98-106; doi:10.2337/diabetes.41.1.98

  4. Lin, J L

    • Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes January 1992 41:22-25; doi:10.2337/diabetes.41.1.22

M

  1. MacDougall, M L

    • Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62

  2. Margolese, H

    • High incidence of thyroiditis and anti-thyroid autoantibodies in NOD mice. Diabetes January 1992 41:40-46; doi:10.2337/diabetes.41.1.40

  3. Marini, M A

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  4. Mathewes, S L

    • Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82

  5. McKnight, G L

    • Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82

  6. Montemurro, A

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  7. Moore, W V

    • Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62

N

  1. Nagai, K

    • Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47

  2. Nakhleh, R E

    • Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53

O

  1. O'Hara, P J

    • Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82

  2. Okamoto, Y

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  3. Oka, Y

    • Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes January 1992 41:22-25; doi:10.2337/diabetes.41.1.22

  4. Orchard, T J

    • Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107

P

  1. Press, M

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  2. Prochazka, M

    • NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes January 1992 41:98-106; doi:10.2337/diabetes.41.1.98

R

  1. Rajotte, R V

    • Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114

  2. Rinaldi, G J

    • Effect of diabetes on fast response to norepinephrine in rat aorta. Diabetes January 1992 41:30-34; doi:10.2337/diabetes.41.1.30

  3. Rivier, J

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  4. Robertson, R P

    • History of Diabetes, the Journal (1952-1991) editor's swan song. Diabetes January 1992 41:1-5; doi:10.2337/diabetes.41.1.1

  5. Ryan, C M

    • Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107

S

  1. Samols, E

    • The vascular order of islet cellular perfusion in the human pancreas. Diabetes January 1992 41:93-97; doi:10.2337/diabetes.41.1.93

  2. Santamaria, P

    • Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53

  3. Seino, S

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  4. Seino, Y

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  5. Serreze, D V

    • NOR/Lt mice: MHC-matched diabetes-resistant control strain for NOD mice. Diabetes January 1992 41:98-106; doi:10.2337/diabetes.41.1.98

  6. Sesti, G

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

  7. Sheppard, M C

    • Effect of Mg2+ on Na(+)-dependent inositol transport. Role for Mg2+ in etiology of diabetic complications. Diabetes January 1992 41:35-39; doi:10.2337/diabetes.41.1.35

  8. Sheppard, P O

    • Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82

  9. Sherwin, R S

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  10. Singh, B

    • Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114

  11. Stagner, J I

    • The vascular order of islet cellular perfusion in the human pancreas. Diabetes January 1992 41:93-97; doi:10.2337/diabetes.41.1.93

  12. Sutherland, D E

    • Characterization of T lymphocytes infiltrating human pancreas allograft affected by isletitis and recurrent diabetes. Diabetes January 1992 41:53-61; doi:10.2337/diabetes.41.1.53

T

  1. Taborsky, G J, Jr

    • Sequence of human galanin and its inhibition of glucose-stimulated insulin secretion from RIN cells. Diabetes January 1992 41:82-87; doi:10.2337/diabetes.41.1.82

  2. Tamborlane, W V

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  3. Thorner, M

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  4. Tsuji, K

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  5. Tsukuda, K

    • Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes January 1992 41:22-25; doi:10.2337/diabetes.41.1.22

U

  1. Ullrich, A

    • Evidence that two naturally occurring human insulin receptor alpha-subunit variants are immunologically distinct. Diabetes January 1992 41:6-11; doi:10.2337/diabetes.41.1.6

V

  1. Vale, W

    • Pituitary response to growth hormone-releasing hormone in IDDM. Abnormal responses to insulin and hyperglycemia. Diabetes January 1992 41:17-21; doi:10.2337/diabetes.41.1.17

  2. Vilstrup, H

    • Glucagon immunoneutralization in diabetic rats normalizes urea synthesis and decreases nitrogen wasting. Diabetes January 1992 41:12-16; doi:10.2337/diabetes.41.1.12

W

  1. Wang, T

    • Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114

  2. Warnock, G L

    • Prevention of recurrence of IDDM in islet-transplanted diabetic NOD mice by adjuvant immunotherapy. Diabetes January 1992 41:114-117; doi:10.2337/diabetes.41.1.114

  3. Ways, J

    • T-lymphocyte lines specific for glutamic acid decarboxylase (GAD) the 64K beta-cell antigen of IDDM. Diabetes January 1992 41:118-121; doi:10.2337/diabetes.41.1.118

  4. Wiegmann, T B

    • Effect of angiotensin-converting enzyme inhibition on renal function and albuminuria in normotensive type I diabetic patients. Diabetes January 1992 41:62-67; doi:10.2337/diabetes.41.1.62

  5. Williams, T M

    • Psychomotor slowing is associated with distal symmetrical polyneuropathy in adults with diabetes mellitus. Diabetes January 1992 41:107-113; doi:10.2337/diabetes.41.1.107

Y

  1. Yagihashi, N

    • Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47

  2. Yagihashi, S

    • Effect of aminoguanidine on functional and structural abnormalities in peripheral nerve of STZ-induced diabetic rats. Diabetes January 1992 41:47-52; doi:10.2337/diabetes.41.1.47

  3. Yamada, Y

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  4. Yang, S D

    • Dysfunction of insulin mediator protein kinase FA in lymphocytes of patients with NIDDM. Diabetes January 1992 41:68-75; doi:10.2337/diabetes.41.1.68

  5. Yano, H

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  6. Yasuda, K

    • Expression of GLUT1 and GLUT2 glucose transporter isoforms in rat islets of Langerhans and their regulation by glucose. Diabetes January 1992 41:76-81; doi:10.2337/diabetes.41.1.76

  7. Yazaki, Y

    • Upregulation of GLUT2 mRNA by glucose, mannose, and fructose in isolated rat hepatocytes. Diabetes January 1992 41:22-25; doi:10.2337/diabetes.41.1.22

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement